Single-daily ceftriaxone plus amikacin versus thrice-daily ceftazidime plus amikacin as empirical treatment of febrile neutropenia in children with cancer

Journal of Paediatrics and Child Health

Volumn 37, Issue 1, 2001, Pages 38-43

  Ariffin, H ^a   Arasu, A ^a   Mahfuzah, M ^b   Ariffin, W A ^a   Chan, L L ^a   Lin, H P ^a  

^a UNIVERSITY MALAYA MEDICAL CENTRE   (Malaysia)

^b HOSPITAL KUALA LUMPUR   (Malaysia)

Author keywords

Cancer; Ceftriaxone; Empirical antibiotic therapy; Febrile neutropenia

Indexed keywords

AMIKACIN; AMPHOTERICIN B; ANTIBIOTIC AGENT; CEFTAZIDIME; CEFTRIAXONE; CEPHALOSPORIN DERIVATIVE;

ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL INFECTION; BLOOD CULTURE; CANCER PATIENT; CHILD; CHILDHOOD CANCER; CLINICAL TRIAL; DRUG HYPERSENSITIVITY; DRUG INDUCED DISEASE; FEBRILE NEUTROPENIA; FEMALE; HUMAN; HYPOKALEMIA; INFECTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

ADOLESCENT; AMIKACIN; ANTI-BACTERIAL AGENTS; BACTEREMIA; CEFTAZIDIME; CEFTRIAXONE; CHILD; CHILD, PRESCHOOL; COST-BENEFIT ANALYSIS; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MULTIVARIATE ANALYSIS; NEOPLASMS; NEUTROPENIA; PROSPECTIVE STUDIES; STATISTICS, NONPARAMETRIC;

EID: 0035112932     PISSN: 10344810     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1754.2001.00585.x     Document Type: Article

References (31)

1. Overview of empiric antibiotic therapy for the febrile neutropenic patient
2. The clinical significance and management of fever in acute myelogenous leukemia
3. Fever, neutropenia and malignancy: A clinical syndrome in evolution
4. Three antibiotic regimens in the treatment of infection in febrile granulocytopenic patients with cancer
5. Combination of amikacin and carbenicillin with or without cefazolin as empiric treatment of febrile neutropenic patients
6. A randomized comparative trial of three aminoglycosides - Comparison of continuous infusions of gentamicin, amikacin and sisomicin with carbenicillin in the treatment of infections in neutropenic patients with malignancies
7. Randomised trial of empiric antibiotic therapy with ticarcillin in combination with gentamicin, amikacin or netilmicin in febrile patients with granulocytopenia and cancer
8. Piperacillin plus amikacin therapy versus carbenicillin plus amikacin therapy in febrile, granulocytopenic patients
9. A randomised study of carbenicillin plus cefamandole or tobramycin in the treatment of febrile episodes in cancer patients
10. Septicemia in granulocytopenic patients; a shift in bacterial etiology
11. Ceftazidime plus amikacin versus ceftazidime plus vancomycin as empiric therapy in febrile neutropenic children with cancer
12. Ceftazidime compared with piperacillin and tobramycin for the empiric treatment of fever in neutropenic patients with cancer
13. Sepsis in neutropenic children with cancer
14. Septicemia in paediatric cancer patients; a 5-year surveillance study in University Hospital, Kuala Lumpur Malaysia
15. Resistance to ceftriaxone and other beta-lactams in bacteria isolated in the community
16. Once-daily aminoglycoside administration: New strategies for an old drug
17. Netilmicin in the treatment of Gram-negative bacteremia: Single-daily versus multiple daily dosage
18. Once versus thrice-daily gentamicin in patients with serious infections
19. Cost of antibiotic therapy in infants and children
20. Epidemiology and outcome of Pseudomonas aeruginosa bacteremia with special emphasis on the influence of antibiotic treatment. Analysis 189 episodes
21. Features of ceftazidime-sensitive and ceftazidime-resistant Klebsiella pneumoniae blood-stream infection in children with febrile neutropania
22. Once daily ceftriaxone plus amikacin vs three times daily ceftazidime plus amikacin for treatment of febrile neutropenic children with cancer
23. Efficacy and toxicity of single-daily doses of amikain and ceftriaxone versus multiple daily doses of amikacin and ceftazidime for infection in patients with cancer and granulocytopenia
24. Piperacillin-tazobactam plus amikacin versus ceftazidime plus amikacin as empiric therapy for fever in granulocytopenic patients with cancer
25. Continuous versus intermittent administration of ceftazidime in experimental Klebsiella pneumoniae pneumonia in normal and leukopenic rats
26. The post antibiotic effect
27. Kinetics of antimicrobial activity
28. New trends in patient management: Risk based therapy for febrile patients with neutropenia
29. Oral ciprofloxacin versus intravenous ceftriazone administered in an outpatient setting for fever and neutopenia in low risk pediatric oncology patients: Randomized prospective trial